Stockreport

Daré Bioscience Distributes Letter to Cerulean Stockholders Outlining Value Proposition and Requesting Favorable Vote at Upcoming Special Stockholder Meeting

CERULEAN PHARMA INC COMMON  (CERU) 
US:NASDAQ Investor Relations: ir.darebioscience.com/investor-relations
PDF WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)-- Cerulean Pharma Inc. (NASDAQ:CERU) and Daré Bioscience, Inc. today announced that Daré Founder and CEO Sabrin [Read more]